Skip to main content

The Effects of MDMA (3,4-methylenedioxymethamphetamine) in Social Cognition in Borderline Personality Disorder

El propósito de este estudio es evaluar los efectos de la MDMA (3,4-metilendioximetanfetamina) sobre la cognición social en adultos con trastorno límite de la personalidad.

Status
recruiting
Phase
Phase 2
Institution
Yale University
Principal investigator
Sarah K Fineberg, MD, PhD
Start date
2025-09-05
End date
2026-09-01
Registry ID
NCT06683014

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.